Benitec Biopharma Ltd
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | 27.7 | 42.4 | 11.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 230.0 | 220.4 | 319.1 | 234.4 | 256.5 | 315.6 | 336.3 | 61.3 | 13.8 | 4.7 | 6.1 | 2.3 | 4.1 | 4.3 | 22.3 | 211.2 | 163.9 | 830.8 | 5,808.2 | 2,057.0 | 19,475.7 | 2,828.9 | 975.8 | 392.1 | 28.2 | 33.5 | 10.4 | 49.1 | 345.1 | 540.6 | 4,266.6 | – | – | – | – | 762.0 | 1,045.5 | 1,116.2 | 950.4 | – | |
| 2.6 | 3.7 | 5.5 | 4.8 | 6.1 | 11.6 | 13.0 | 6.6 | 4.4 | 3.9 | 3.7 | 2.3 | 1.5 | 0.5 | 1.2 | 3.4 | 3.6 | 3.5 | 9.0 | 6.1 | 7.6 | 7.8 | 10.0 | 13.6 | 1.1 | 2.1 | 1.2 | 132.9 | 1.2 | 2.1 | 4.8 | 1.5 | 1.5 | 3.7 | 5.1 | 4.4 | 6.2 | 3.3 | 2.9 | 3.5 | |
| – | – | – | – | – | – | 315.6 | 53.3 | 11.2 | 3.7 | 6.1 | 1.0 | 4.0 | -3.0 | 5.9 | 152.8 | 121.3 | 608.5 | 5,115.2 | 1,725.5 | 16,904.9 | 2,425.6 | 866.8 | 354.0 | -0.4 | 15.1 | -0.7 | 45.1 | 4.0 | 211.3 | 3,201.1 | – | – | – | – | 586.8 | 876.3 | 777.5 | 619.0 | – | |
| – | – | – | – | – | – | – | – | – | 12.3 | 25.1 | 4.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 1,682.8 | 55.6 | 36.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -34.4% | -29.1% | -8.0% | -10.6% | -7.2% | -4.9% | -8.6% | -12.1% | -2.0% | 0.1% | 1.8% | 2.7% | -16.3% | -91.7% | -32.3% | -24.5% | -35.4% | -19.8% | -11.3% | -10.8% | -12.6% | -17.2% | -21.4% | -40.2% | -96.7% | -96.3% | -317.3% | -66.1% | -70.6% | -53.9% | -36.4% | -27.8% | -20.0% | -7.9% | -3.7% | -5.6% | -3.9% | -3.0% | -3.9% | -2.7% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 58.6% | 48.4% | 35.7% | 53.9% | 53.3% | 56.8% | 46.8% | 6.4% | 82.1% | 88.9% | 89.8% | 96.4% | 95.9% | 116.6% | 124.5% | 264.5% | 202.7% | -287.1% | -900.0% | -108.5% | -1,439.9% | -273.0% | -36.3% | -38.0% | -6.7% | -8.8% | -7.6% | -4.9% | 241.3% | 272.1% | 884.6% | – | – | – | – | 0.0% | -4.9% | -11.9% | -14.2% | – | |
| -7,340.8% | -5,937.4% | -3,974.0% | -3,532.0% | -3,176.0% | -2,481.9% | -2,739.4% | -674.5% | -33.7% | 23.4% | 20.2% | 20.1% | -27.8% | -499.7% | -922.0% | -6,745.4% | -7,070.5% | -19,823.9% | -74,288.2% | -23,045.8% | -260,327.7% | -57,602.7% | -22,029.5% | -17,847.5% | -3,090.0% | -3,289.4% | -3,410.4% | -3,488.3% | -27,166.7% | -35,560.7% | -165,323.1% | – | – | – | – | -7,511.7% | -8,233.3% | -8,695.9% | -8,380.6% | – | |
| -6,619.2% | -5,349.5% | -3,218.8% | -2,309.9% | -3,201.9% | -2,183.0% | -3,026.8% | -743.0% | -39.5% | 17.1% | 14.4% | 20.3% | -31.6% | -491.3% | -910.3% | -6,730.3% | -7,088.9% | -19,911.1% | -75,376.5% | -23,528.8% | -268,272.1% | -59,177.2% | -22,252.8% | -18,200.4% | -3,202.8% | -3,371.4% | -3,534.2% | -3,576.2% | -27,230.7% | -35,754.1% | -166,861.5% | – | – | – | – | -8,140.1% | -8,842.6% | -9,253.6% | -8,792.1% | – | |
| -7,905.5% | -6,403.7% | -2,544.8% | -2,482.3% | -1,836.5% | -1,547.9% | -2,875.7% | -741.6% | -27.4% | 0.3% | 11.0% | 6.3% | -65.9% | -391.9% | -721.0% | -5,173.6% | -5,804.9% | -16,489.8% | -65,852.9% | -22,123.7% | -244,918.9% | -48,738.4% | -20,845.8% | -15,767.3% | -2,726.5% | -3,227.2% | -3,300.3% | -3,245.8% | -24,381.7% | -29,142.3% | -155,114.7% | – | – | – | – | -4,302.5% | -4,080.4% | -3,373.9% | -3,704.1% | – | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -75.8% | -89.1% | -55.5% | -47.5% | -76.6% | -80.0% | -116.7% | -79.7% | -12.7% | 13.9% | 8.7% | 20.4% | -11.6% | -60.3% | -50.4% | -108.1% | -156.2% | -84.6% | -117.2% | -69.4% | -104.7% | -164.1% | -228.0% | -631.8% | -124.9% | -209.5% | -423.7% | -9,684.2% | -91.6% | -141.0% | -188.6% | -46.0% | -32.5% | -31.1% | -34.7% | -46.5% | -52.5% | -27.5% | -26.7% | -25.7% | |
| -72.3% | -82.8% | -52.9% | -45.1% | -70.2% | -71.8% | -103.2% | -70.0% | -11.8% | 12.9% | 376.0% | 12.3% | -928.0% | -56.3% | -45.8% | -95.5% | -135.5% | -79.7% | -95.4% | -64.9% | -90.9% | -126.9% | -170.3% | -304.8% | -100.8% | -158.3% | -242.9% | -438.2% | -75.5% | -102.1% | -144.6% | -41.7% | -30.3% | -29.9% | -32.2% | -45.4% | -51.2% | -27.0% | -26.1% | -24.9% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | -8.1 | -12 | -23 | -16 | -0.5 | -22 | -0.3 | -14 | -18 | -9.6 | -7.3 | -14 | -12 | -20 | -16 | -12 | -8.4 | -3.8 | -16 | -10 | -6.3 | -2.2 | -26 | -20 | -14 | -51 | -68 | -78 | -103 | -97 | -94 | -188 | -184 | -179 | |
| – | – | – | – | – | – | – | – | – | -3.3 | -0.1 | -6.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 95.4% | 93.0% | 95.3% | 94.9% | 91.5% | 89.7% | 88.5% | 87.8% | 92.9% | 92.9% | 4,323.1% | 60.2% | 8,007.6% | 93.4% | 90.8% | 88.4% | 86.8% | 94.3% | 81.4% | 93.6% | 86.8% | 77.3% | 74.7% | 48.3% | 80.7% | 75.5% | 57.3% | 4.5% | 82.5% | 72.4% | 76.7% | 90.5% | 93.3% | 96.0% | 92.7% | 97.7% | 97.5% | 98.3% | 98.0% | 96.9% | |
| – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 1.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -102.74 | -92.85 | -72.02 | -47.75 | -70.04 | -52.92 | -73.45 | -61.78 | -17.55 | 13.79 | 12.04 | 16.77 | -14.13 | -149.44 | -40.61 | -42.80 | -46.33 | -12.22 | -11.47 | -8.36 | -8.43 | -9.25 | -8.92 | -9.47 | -7.15 | -2.91 | -12.13 | -2.97 | -2.37 | -2.12 | -2.07 | -2.16 | -1.96 | -1.07 | -0.88 | -1.25 | -1.18 | -1.12 | -0.99 | -0.98 | |
| 1.55 | 1.74 | 2.24 | 2.07 | 2.19 | 2.42 | 2.43 | 8.32 | 44.47 | 80.61 | 83.53 | 82.40 | 44.67 | 30.42 | 4.46 | 0.64 | 0.65 | 0.06 | 0.02 | 0.04 | 0.00 | 0.02 | 0.04 | 0.05 | 0.22 | 0.09 | 0.34 | 0.08 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 | -0.02 | |
| 135.56 | 104.24 | 129.69 | 100.54 | 91.40 | 66.17 | 62.96 | 77.54 | 138.39 | 98.98 | 138.45 | 82.20 | 121.95 | 248.01 | 80.61 | 39.59 | 29.66 | 14.45 | 9.79 | 12.05 | 8.05 | 5.64 | 3.91 | 1.50 | 5.72 | 1.39 | 2.86 | 0.03 | 2.59 | 1.50 | 1.10 | 4.68 | 6.03 | 3.44 | 2.53 | 2.69 | 2.25 | 4.08 | 3.71 | 3.80 | |
| -122.71 | -111.15 | -56.94 | -51.32 | -40.17 | -37.52 | -69.78 | -61.66 | -12.18 | 0.23 | 9.18 | 5.19 | -29.42 | -119.21 | -32.16 | -32.90 | -37.94 | -10.12 | -10.02 | -7.86 | -7.70 | -7.62 | -8.35 | -8.20 | -6.08 | -2.78 | -11.33 | -2.70 | -2.12 | -1.72 | -1.93 | -1.95 | -1.84 | -1.00 | -0.48 | -0.66 | -0.55 | -0.41 | -0.42 | -0.37 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.